Deardorf Caren Insider Trades

Insider Trading History

Track insider trading activity for Deardorf Caren. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.86M 22,225 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.90
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.37M 16,300 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$83.90
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.05M 12,500 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 12,500 shares
$44.71
$83.90
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.47M 17,500 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$356k 17,500 shares
$20.32
$83.90
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $13.8k 19,762 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.45k 3,000 shares
$1.15
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Commercial Officer
Holding Value $1.97M 19,762 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.45k 3,000 shares
$1.15
$99.91
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $52.5k 75,000 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 75,000 shares
$1.57
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Commercial Officer
Holding Value $7.49M 75,000 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 75,000 shares
$1.57
$99.91
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $367k 4,375 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80k 4,375 shares
$18.29
$83.90
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Commercial Officer
Holding Value $1.67M 16,762 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.48k 3,000 shares
$1.16
$99.91
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $11.7k 16,762 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.48k 3,000 shares
$1.16
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Commercial Officer
Holding Value $5M 50,000 shares
Last Trade
May 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59k 50,000 shares
$1.18
$99.91
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $35k 50,000 shares
Last Trade
May 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59k 50,000 shares
$1.18
$0.70
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $2.94M 35,000 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$676k 35,000 shares
$19.30
$83.90
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $2.1M 25,000 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$483k 25,000 shares
$19.30
$83.90
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $52.5k 75,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 75,000 shares
$3.19
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Commercial Officer
Holding Value $7.49M 75,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 75,000 shares
$3.19
$99.91
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $9.63k 13,762 shares
Last Trade
Sep 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$42k 6,238 shares
$6.73
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $14k 20,000 shares
Last Trade
Sep 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 20,000 shares
$6.13
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Commercial Officer
Holding Value $140k 200,000 shares
Last Trade
Jul 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.88M 200,000 shares
$9.41
$0.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up